Optimizing Collaboration with Industry Partners
Enhance collaboration with industry partners by exploring strategies at the EPF Annual Industry Roundtable in Brussels on 15th September 2016. Join us to boost partnerships and drive innovation through insightful discussions and networking opportunities.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
HOW CAN WE OPTIMISE COLLABORATION WITH INDUSTRY PARTNERS ? EPF ANNUAL INDUSTRY ROUNDTABLE Brussels 15 September 2016
Evolving nature of collaboration Starting point EPF financial framework Based on dialogue, mutual respect, transparency and independence. Distinct elements: Unrestricted support for EPF to pursue our activities the added value of a vibrant patients movement Public Private Partnerships EUPATI, ADAPT SMART Multi stakeholder initiatives where EPF contributes, e.g. European Health Parliament, Societal Impact of Pain Bilateral dialogue and information exchange Promotion of meaningful patient engagement within companies
Optimising the collaboration Focus, streamline, simplify. Objectives to optimise our human resources and capacity to focus on dialogue, quality outcomes and delivery in line with our strategy to foster trust and confidence in our relationship with industry partners as a fellow stakeholders in the health community to ensure EPF is able to grow wisely, to respond to the needs of the patient movement in Europe and to contribute as a key player
Optimising the collaboration Focus, streamline, simplify. Strategic relationships with companies small internal team led by one reference person, liaising with EPF Clarity on what trade associations are driving forward and what individual companies are working on optimising synergies Ensuring the effectiveness of the regular dialogue meetings now in place EPFIA Patient Think Tank Patient MedTech Dialogue, Patients, Medicines for Europe Dialogue, COCIR dialogue on integrated care
Example of how we work EPF capacity building programme, evolving with industry support and experts Unrestricted funding for broad programme Guidance from local companies in working with different stakeholders Increasingly collaboration with national trade associations Contribution to training modules - eg transparency guidelines and implementation of the EFPIA code Input from industry on process and outcome evaluation
Funding processes Focus, streamline, simplify. Swift decisions on funding amount in autumn for budget planning following year - sustainability EPF internal taskforce on finance - excellent financial governance Clear pathway and support to ensure paperwork is completed with minimal delay and the funding transferred - key for cash flow - ever more critical as EPF grows Aim to complete all contracts by first six months of the year
Outstanding Challenges On-line disease specific applications not always suited to EPF as an umbrella Highly divergent and sometimes complex contractual processes Reporting- accountability key - but detailed templates are time-consuming and duplicate our own rigorous reporting and evaluation ( which meets EU requirements) Is there a role for European trade associations to streamline and harmonise these processes, respecting compliance, proportionality, etc ?
Discussion Focus, streamline, simplify. Feedback on our approach? How can we improve, as an organisation in managing relationships with industry ? Advice on the challenges raised and how these could be overcome ? NOT only for today an ongoing discussion!
THANK YOU FOR YOUR ATTENTION! Follow us on Social Medias! /eupatient /europeanpatientsforum eu-patient.eu/blog /eupatientsforum More information www.eu-patient.eu info@eu-patient.eu
